Metastatic colorectal cancer cells from patients previously treated with chemotherapy are sensitive to T-cell killing mediated by CEA/CD3-bispecific T-cell-engaging BiTE ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2010-01

AUTHORS

T Osada, D Hsu, S Hammond, A Hobeika, G Devi, T M Clay, H K Lyerly, M A Morse

ABSTRACT

BACKGROUND: Novel technologies to redirect T-cell killing against cancer cells are emerging. We hypothesised that metastatic human colorectal cancer (CRC) previously treated with conventional chemotherapy would be sensitive to T-cell killing mediated by carcinoembryonic antigen (CEA)/CD3-bispecific T-cell-engaging BiTE antibody (MEDI-565). METHODS: We analysed proliferation and lysis of CEA-positive (CEA+) CRC specimens that had survived previous systemic chemotherapy and biologic therapy to determine whether they could be killed by patient T cells engaged by MEDI-565 in vitro. RESULTS: At low concentrations (0.1-1 ng ml(-1)), MEDI-565+ T cells caused reduced proliferation and enhanced apoptosis of CEA+ human CRC specimens. High levels of soluble CEA did not impair killing by redirected T cells and there was no increase in resistance to T-cell killing despite multiple rounds of exposure. CONCLUSIONS: This study shows for the first time that metastatic CRC specimens derived from patients previously treated with conventional chemotherapy can be lysed by patient T cells. Clinical testing of cancer immunotherapies, such as MEDI-565 that result in exposure of tumours to large numbers of T cells, is warranted. More... »

PAGES

124

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.bjc.6605364

DOI

http://dx.doi.org/10.1038/sj.bjc.6605364

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1022579921

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/19953093


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adenocarcinoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Bispecific", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Apoptosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "CD3 Complex", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoembryonic Antigen", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Colorectal Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cytotoxicity, Immunologic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Resistance, Neoplasm", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fas Ligand Protein", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Granzymes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Liver Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphocyte Activation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice, Inbred NOD", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Organoplatinum Compounds", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Oxaliplatin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "T-Lymphocytes, Cytotoxic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "fas Receptor", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Duke University", 
          "id": "https://www.grid.ac/institutes/grid.26009.3d", 
          "name": [
            "Department of Surgery, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA", 
            "Program in Molecular Therapeutics, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA", 
            "Duke Comprehensive Cancer Center, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Osada", 
        "givenName": "T", 
        "id": "sg:person.01114717615.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01114717615.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.189509.c", 
          "name": [
            "Duke Comprehensive Cancer Center, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA", 
            "Department of Medicine, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA", 
            "Duke Institute for Genome Sciences & Policy, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hsu", 
        "givenName": "D", 
        "id": "sg:person.0652031333.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0652031333.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "AstraZeneca (United States)", 
          "id": "https://www.grid.ac/institutes/grid.418152.b", 
          "name": [
            "MedImmune, LLC, One MedImmune Way, Gaithersburg, MD 20878, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hammond", 
        "givenName": "S", 
        "id": "sg:person.0726645175.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0726645175.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University", 
          "id": "https://www.grid.ac/institutes/grid.26009.3d", 
          "name": [
            "Department of Surgery, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA", 
            "Program in Molecular Therapeutics, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA", 
            "Duke Comprehensive Cancer Center, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hobeika", 
        "givenName": "A", 
        "id": "sg:person.07741424047.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07741424047.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University", 
          "id": "https://www.grid.ac/institutes/grid.26009.3d", 
          "name": [
            "Department of Surgery, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA", 
            "Program in Molecular Therapeutics, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA", 
            "Duke Comprehensive Cancer Center, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Devi", 
        "givenName": "G", 
        "id": "sg:person.01023745630.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01023745630.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University", 
          "id": "https://www.grid.ac/institutes/grid.26009.3d", 
          "name": [
            "Department of Surgery, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA", 
            "Program in Molecular Therapeutics, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA", 
            "Duke Comprehensive Cancer Center, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Clay", 
        "givenName": "T M", 
        "id": "sg:person.0706420433.90", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0706420433.90"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.189509.c", 
          "name": [
            "Department of Surgery, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA", 
            "Program in Molecular Therapeutics, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA", 
            "Duke Comprehensive Cancer Center, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA", 
            "Department of Pathology, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA", 
            "Department of Immunology, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lyerly", 
        "givenName": "H K", 
        "id": "sg:person.012507420117.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012507420117.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.189509.c", 
          "name": [
            "Program in Molecular Therapeutics, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA", 
            "Duke Comprehensive Cancer Center, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA", 
            "Department of Medicine, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Morse", 
        "givenName": "M A", 
        "id": "sg:person.013700705377.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013700705377.06"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/j.molimm.2005.07.034", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000050936"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.molimm.2005.07.034", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000050936"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00262-007-0298-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000839796", 
          "https://doi.org/10.1007/s00262-007-0298-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00262-007-0298-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000839796", 
          "https://doi.org/10.1007/s00262-007-0298-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/intimm/8.1.57", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004403567"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ijc.20908", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011506028"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00002371-200307000-00005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014162674"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00002371-200307000-00005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014162674"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00002371-200307000-00005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014162674"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1006/scbi.1998.0119", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024485267"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nri1983", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026188939", 
          "https://doi.org/10.1038/nri1983"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nri1983", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026188939", 
          "https://doi.org/10.1038/nri1983"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10549-008-0185-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026190668", 
          "https://doi.org/10.1007/s10549-008-0185-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10549-008-0185-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026190668", 
          "https://doi.org/10.1007/s10549-008-0185-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1146/annurev.immunol.25.022106.141527", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029126035"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-06-2760", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029642086"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00262-005-0001-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029966967", 
          "https://doi.org/10.1007/s00262-005-0001-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00262-005-0001-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029966967", 
          "https://doi.org/10.1007/s00262-005-0001-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00262-003-0496-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034809523", 
          "https://doi.org/10.1007/s00262-003-0496-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1359-6446(05)03554-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035538151"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1359-6446(05)03554-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035538151"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ijc.2910570113", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042755426"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/cji.0b013e318156750c", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048770926"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/cji.0b013e318156750c", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048770926"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4049/jimmunol.170.8.4397", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049032729"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdi320", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049789238"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1081/cnv-58878", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051008276"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1081/cnv-58878", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051008276"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.molimm.2005.03.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051763905"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/cji.0b013e31819b7c70", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052604096"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/cji.0b013e31819b7c70", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052604096"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/cji.0b013e31819b7c70", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052604096"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1074/jbc.m413303200", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052813211"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.1158545", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062457773"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2003.09.027", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064203833"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074641647", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075286407", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2010-01", 
    "datePublishedReg": "2010-01-01", 
    "description": "BACKGROUND: Novel technologies to redirect T-cell killing against cancer cells are emerging. We hypothesised that metastatic human colorectal cancer (CRC) previously treated with conventional chemotherapy would be sensitive to T-cell killing mediated by carcinoembryonic antigen (CEA)/CD3-bispecific T-cell-engaging BiTE antibody (MEDI-565).\nMETHODS: We analysed proliferation and lysis of CEA-positive (CEA+) CRC specimens that had survived previous systemic chemotherapy and biologic therapy to determine whether they could be killed by patient T cells engaged by MEDI-565 in vitro.\nRESULTS: At low concentrations (0.1-1 ng ml(-1)), MEDI-565+ T cells caused reduced proliferation and enhanced apoptosis of CEA+ human CRC specimens. High levels of soluble CEA did not impair killing by redirected T cells and there was no increase in resistance to T-cell killing despite multiple rounds of exposure.\nCONCLUSIONS: This study shows for the first time that metastatic CRC specimens derived from patients previously treated with conventional chemotherapy can be lysed by patient T cells. Clinical testing of cancer immunotherapies, such as MEDI-565 that result in exposure of tumours to large numbers of T cells, is warranted.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/sj.bjc.6605364", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2416449", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2435718", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "102"
      }
    ], 
    "name": "Metastatic colorectal cancer cells from patients previously treated with chemotherapy are sensitive to T-cell killing mediated by CEA/CD3-bispecific T-cell-engaging BiTE antibody", 
    "pagination": "124", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "6b932aaac98883b22bac9b76d20ad8866df0f328d6dd19ecb269875bb3fe0e1a"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "19953093"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0370635"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.bjc.6605364"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1022579921"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.bjc.6605364", 
      "https://app.dimensions.ai/details/publication/pub.1022579921"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T09:38", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000346_0000000346/records_99833_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/6605364"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6605364'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6605364'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6605364'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6605364'


 

This table displays all metadata directly associated to this object as RDF triples.

298 TRIPLES      21 PREDICATES      75 URIs      42 LITERALS      30 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.bjc.6605364 schema:about N0b67380ff4dd419195143a77309b4af4
2 N12bf9cf24b7849759516cb7b64efea5e
3 N14d3ad8ebf8d4dde85971a003f482161
4 N1aaefeecf7ff420c80b789d5be83938e
5 N1d1e76dde4e748a1bddd7a5a78580f00
6 N23190abdb54747f9841af3d93c215b19
7 N307fce80db9b4de293d36a9e4b1e5a22
8 N417cda80cdda45d481f68f91c169653d
9 N44ef5a3f5aa14f2e8de5758ef4c492b4
10 N46ecdd6ebfc14ffcb33fa4f356dc5703
11 N55572f7a8a464385a3c87c170e4e9908
12 N6231fecf228e4a63bb42278bcc74db02
13 N6c908b74655b4bfe860619b91a66a5d8
14 N6e11bf43c1e54942bda7ba4c22af3317
15 N7b59f5463fd64b43b425c83a73feb745
16 N7c8a897247bc455998c1639d297a3e65
17 N894f38c1177f43a4b42b7f053b516f97
18 N9fe5fb49ad304b6ca88ee759b2fc9784
19 Na3170b6f393d47699e75746f8daac5f3
20 Ne52eb827c0f144e3ab541197f42eea39
21 Nede2123d478b4264a67e4e4802b667a7
22 anzsrc-for:11
23 anzsrc-for:1112
24 schema:author N029114f285ae43bf97c1449bb46dbc02
25 schema:citation sg:pub.10.1007/s00262-003-0496-2
26 sg:pub.10.1007/s00262-005-0001-1
27 sg:pub.10.1007/s00262-007-0298-z
28 sg:pub.10.1007/s10549-008-0185-0
29 sg:pub.10.1038/nri1983
30 https://app.dimensions.ai/details/publication/pub.1074641647
31 https://app.dimensions.ai/details/publication/pub.1075286407
32 https://doi.org/10.1002/ijc.20908
33 https://doi.org/10.1002/ijc.2910570113
34 https://doi.org/10.1006/scbi.1998.0119
35 https://doi.org/10.1016/j.molimm.2005.03.007
36 https://doi.org/10.1016/j.molimm.2005.07.034
37 https://doi.org/10.1016/s1359-6446(05)03554-3
38 https://doi.org/10.1074/jbc.m413303200
39 https://doi.org/10.1081/cnv-58878
40 https://doi.org/10.1093/annonc/mdi320
41 https://doi.org/10.1093/intimm/8.1.57
42 https://doi.org/10.1097/00002371-200307000-00005
43 https://doi.org/10.1097/cji.0b013e318156750c
44 https://doi.org/10.1097/cji.0b013e31819b7c70
45 https://doi.org/10.1126/science.1158545
46 https://doi.org/10.1146/annurev.immunol.25.022106.141527
47 https://doi.org/10.1158/0008-5472.can-06-2760
48 https://doi.org/10.1200/jco.2003.09.027
49 https://doi.org/10.4049/jimmunol.170.8.4397
50 schema:datePublished 2010-01
51 schema:datePublishedReg 2010-01-01
52 schema:description BACKGROUND: Novel technologies to redirect T-cell killing against cancer cells are emerging. We hypothesised that metastatic human colorectal cancer (CRC) previously treated with conventional chemotherapy would be sensitive to T-cell killing mediated by carcinoembryonic antigen (CEA)/CD3-bispecific T-cell-engaging BiTE antibody (MEDI-565). METHODS: We analysed proliferation and lysis of CEA-positive (CEA+) CRC specimens that had survived previous systemic chemotherapy and biologic therapy to determine whether they could be killed by patient T cells engaged by MEDI-565 in vitro. RESULTS: At low concentrations (0.1-1 ng ml(-1)), MEDI-565+ T cells caused reduced proliferation and enhanced apoptosis of CEA+ human CRC specimens. High levels of soluble CEA did not impair killing by redirected T cells and there was no increase in resistance to T-cell killing despite multiple rounds of exposure. CONCLUSIONS: This study shows for the first time that metastatic CRC specimens derived from patients previously treated with conventional chemotherapy can be lysed by patient T cells. Clinical testing of cancer immunotherapies, such as MEDI-565 that result in exposure of tumours to large numbers of T cells, is warranted.
53 schema:genre research_article
54 schema:inLanguage en
55 schema:isAccessibleForFree true
56 schema:isPartOf N4ccac0f155de4838a9c0f45f2f463fcc
57 Nac546f26edfa43bc996db5af96bd900b
58 sg:journal.1017082
59 schema:name Metastatic colorectal cancer cells from patients previously treated with chemotherapy are sensitive to T-cell killing mediated by CEA/CD3-bispecific T-cell-engaging BiTE antibody
60 schema:pagination 124
61 schema:productId N0317f7ba3af94ca4adc7c97d428ad0ef
62 N1772d9743eca457d984b266fb3622234
63 N27072f2130ce42f6b702d9759dfac477
64 N48abc183ade44560a8e5b0b3b5d4b141
65 Nce519eb038664849b976d57ae75fa42b
66 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022579921
67 https://doi.org/10.1038/sj.bjc.6605364
68 schema:sdDatePublished 2019-04-11T09:38
69 schema:sdLicense https://scigraph.springernature.com/explorer/license/
70 schema:sdPublisher Nb95fa9a6950b4670af00095dbd6238d5
71 schema:url https://www.nature.com/articles/6605364
72 sgo:license sg:explorer/license/
73 sgo:sdDataset articles
74 rdf:type schema:ScholarlyArticle
75 N029114f285ae43bf97c1449bb46dbc02 rdf:first sg:person.01114717615.49
76 rdf:rest N5b5a5bfd5ffd4ac38e397f85781eb8d4
77 N0317f7ba3af94ca4adc7c97d428ad0ef schema:name dimensions_id
78 schema:value pub.1022579921
79 rdf:type schema:PropertyValue
80 N0b67380ff4dd419195143a77309b4af4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name T-Lymphocytes, Cytotoxic
82 rdf:type schema:DefinedTerm
83 N12bf9cf24b7849759516cb7b64efea5e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Mice, Inbred NOD
85 rdf:type schema:DefinedTerm
86 N14d3ad8ebf8d4dde85971a003f482161 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Adenocarcinoma
88 rdf:type schema:DefinedTerm
89 N1772d9743eca457d984b266fb3622234 schema:name pubmed_id
90 schema:value 19953093
91 rdf:type schema:PropertyValue
92 N1aaefeecf7ff420c80b789d5be83938e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Apoptosis
94 rdf:type schema:DefinedTerm
95 N1d1e76dde4e748a1bddd7a5a78580f00 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Humans
97 rdf:type schema:DefinedTerm
98 N23190abdb54747f9841af3d93c215b19 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Animals
100 rdf:type schema:DefinedTerm
101 N27072f2130ce42f6b702d9759dfac477 schema:name nlm_unique_id
102 schema:value 0370635
103 rdf:type schema:PropertyValue
104 N307fce80db9b4de293d36a9e4b1e5a22 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Mice
106 rdf:type schema:DefinedTerm
107 N3c636736ab314601b3a56d70b2a1ca85 rdf:first sg:person.012507420117.48
108 rdf:rest N5e216f359869407794e7b494905ebd77
109 N417cda80cdda45d481f68f91c169653d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Colorectal Neoplasms
111 rdf:type schema:DefinedTerm
112 N44ef5a3f5aa14f2e8de5758ef4c492b4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Carcinoembryonic Antigen
114 rdf:type schema:DefinedTerm
115 N46ecdd6ebfc14ffcb33fa4f356dc5703 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Granzymes
117 rdf:type schema:DefinedTerm
118 N48abc183ade44560a8e5b0b3b5d4b141 schema:name doi
119 schema:value 10.1038/sj.bjc.6605364
120 rdf:type schema:PropertyValue
121 N4ccac0f155de4838a9c0f45f2f463fcc schema:issueNumber 1
122 rdf:type schema:PublicationIssue
123 N55572f7a8a464385a3c87c170e4e9908 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Oxaliplatin
125 rdf:type schema:DefinedTerm
126 N5b5a5bfd5ffd4ac38e397f85781eb8d4 rdf:first sg:person.0652031333.36
127 rdf:rest Nb9deb71740d64aeebb69d905554202f1
128 N5e216f359869407794e7b494905ebd77 rdf:first sg:person.013700705377.06
129 rdf:rest rdf:nil
130 N6231fecf228e4a63bb42278bcc74db02 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name CD3 Complex
132 rdf:type schema:DefinedTerm
133 N6c908b74655b4bfe860619b91a66a5d8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Drug Resistance, Neoplasm
135 rdf:type schema:DefinedTerm
136 N6e11bf43c1e54942bda7ba4c22af3317 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Antineoplastic Combined Chemotherapy Protocols
138 rdf:type schema:DefinedTerm
139 N79250f0c12b9458daeb22dd7d40acf6e rdf:first sg:person.0706420433.90
140 rdf:rest N3c636736ab314601b3a56d70b2a1ca85
141 N7b59f5463fd64b43b425c83a73feb745 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Organoplatinum Compounds
143 rdf:type schema:DefinedTerm
144 N7c8a897247bc455998c1639d297a3e65 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Fas Ligand Protein
146 rdf:type schema:DefinedTerm
147 N894f38c1177f43a4b42b7f053b516f97 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Lymphocyte Activation
149 rdf:type schema:DefinedTerm
150 N9fe5fb49ad304b6ca88ee759b2fc9784 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Antibodies, Bispecific
152 rdf:type schema:DefinedTerm
153 Na3170b6f393d47699e75746f8daac5f3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name fas Receptor
155 rdf:type schema:DefinedTerm
156 Nac546f26edfa43bc996db5af96bd900b schema:volumeNumber 102
157 rdf:type schema:PublicationVolume
158 Nb95fa9a6950b4670af00095dbd6238d5 schema:name Springer Nature - SN SciGraph project
159 rdf:type schema:Organization
160 Nb9deb71740d64aeebb69d905554202f1 rdf:first sg:person.0726645175.21
161 rdf:rest Ne9f9a19f08a940019e6e4338d6fb9996
162 Nce519eb038664849b976d57ae75fa42b schema:name readcube_id
163 schema:value 6b932aaac98883b22bac9b76d20ad8866df0f328d6dd19ecb269875bb3fe0e1a
164 rdf:type schema:PropertyValue
165 Ne52eb827c0f144e3ab541197f42eea39 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Liver Neoplasms
167 rdf:type schema:DefinedTerm
168 Ne9f9a19f08a940019e6e4338d6fb9996 rdf:first sg:person.07741424047.51
169 rdf:rest Nf6d7b1030a7c44de85db1531c8ab6efe
170 Nede2123d478b4264a67e4e4802b667a7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Cytotoxicity, Immunologic
172 rdf:type schema:DefinedTerm
173 Nf6d7b1030a7c44de85db1531c8ab6efe rdf:first sg:person.01023745630.53
174 rdf:rest N79250f0c12b9458daeb22dd7d40acf6e
175 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
176 schema:name Medical and Health Sciences
177 rdf:type schema:DefinedTerm
178 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
179 schema:name Oncology and Carcinogenesis
180 rdf:type schema:DefinedTerm
181 sg:grant.2416449 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.bjc.6605364
182 rdf:type schema:MonetaryGrant
183 sg:grant.2435718 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.bjc.6605364
184 rdf:type schema:MonetaryGrant
185 sg:journal.1017082 schema:issn 0007-0920
186 1532-1827
187 schema:name British Journal of Cancer
188 rdf:type schema:Periodical
189 sg:person.01023745630.53 schema:affiliation https://www.grid.ac/institutes/grid.26009.3d
190 schema:familyName Devi
191 schema:givenName G
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01023745630.53
193 rdf:type schema:Person
194 sg:person.01114717615.49 schema:affiliation https://www.grid.ac/institutes/grid.26009.3d
195 schema:familyName Osada
196 schema:givenName T
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01114717615.49
198 rdf:type schema:Person
199 sg:person.012507420117.48 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
200 schema:familyName Lyerly
201 schema:givenName H K
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012507420117.48
203 rdf:type schema:Person
204 sg:person.013700705377.06 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
205 schema:familyName Morse
206 schema:givenName M A
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013700705377.06
208 rdf:type schema:Person
209 sg:person.0652031333.36 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
210 schema:familyName Hsu
211 schema:givenName D
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0652031333.36
213 rdf:type schema:Person
214 sg:person.0706420433.90 schema:affiliation https://www.grid.ac/institutes/grid.26009.3d
215 schema:familyName Clay
216 schema:givenName T M
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0706420433.90
218 rdf:type schema:Person
219 sg:person.0726645175.21 schema:affiliation https://www.grid.ac/institutes/grid.418152.b
220 schema:familyName Hammond
221 schema:givenName S
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0726645175.21
223 rdf:type schema:Person
224 sg:person.07741424047.51 schema:affiliation https://www.grid.ac/institutes/grid.26009.3d
225 schema:familyName Hobeika
226 schema:givenName A
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07741424047.51
228 rdf:type schema:Person
229 sg:pub.10.1007/s00262-003-0496-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034809523
230 https://doi.org/10.1007/s00262-003-0496-2
231 rdf:type schema:CreativeWork
232 sg:pub.10.1007/s00262-005-0001-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029966967
233 https://doi.org/10.1007/s00262-005-0001-1
234 rdf:type schema:CreativeWork
235 sg:pub.10.1007/s00262-007-0298-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1000839796
236 https://doi.org/10.1007/s00262-007-0298-z
237 rdf:type schema:CreativeWork
238 sg:pub.10.1007/s10549-008-0185-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026190668
239 https://doi.org/10.1007/s10549-008-0185-0
240 rdf:type schema:CreativeWork
241 sg:pub.10.1038/nri1983 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026188939
242 https://doi.org/10.1038/nri1983
243 rdf:type schema:CreativeWork
244 https://app.dimensions.ai/details/publication/pub.1074641647 schema:CreativeWork
245 https://app.dimensions.ai/details/publication/pub.1075286407 schema:CreativeWork
246 https://doi.org/10.1002/ijc.20908 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011506028
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1002/ijc.2910570113 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042755426
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1006/scbi.1998.0119 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024485267
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1016/j.molimm.2005.03.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051763905
253 rdf:type schema:CreativeWork
254 https://doi.org/10.1016/j.molimm.2005.07.034 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000050936
255 rdf:type schema:CreativeWork
256 https://doi.org/10.1016/s1359-6446(05)03554-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035538151
257 rdf:type schema:CreativeWork
258 https://doi.org/10.1074/jbc.m413303200 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052813211
259 rdf:type schema:CreativeWork
260 https://doi.org/10.1081/cnv-58878 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051008276
261 rdf:type schema:CreativeWork
262 https://doi.org/10.1093/annonc/mdi320 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049789238
263 rdf:type schema:CreativeWork
264 https://doi.org/10.1093/intimm/8.1.57 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004403567
265 rdf:type schema:CreativeWork
266 https://doi.org/10.1097/00002371-200307000-00005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014162674
267 rdf:type schema:CreativeWork
268 https://doi.org/10.1097/cji.0b013e318156750c schema:sameAs https://app.dimensions.ai/details/publication/pub.1048770926
269 rdf:type schema:CreativeWork
270 https://doi.org/10.1097/cji.0b013e31819b7c70 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052604096
271 rdf:type schema:CreativeWork
272 https://doi.org/10.1126/science.1158545 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062457773
273 rdf:type schema:CreativeWork
274 https://doi.org/10.1146/annurev.immunol.25.022106.141527 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029126035
275 rdf:type schema:CreativeWork
276 https://doi.org/10.1158/0008-5472.can-06-2760 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029642086
277 rdf:type schema:CreativeWork
278 https://doi.org/10.1200/jco.2003.09.027 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064203833
279 rdf:type schema:CreativeWork
280 https://doi.org/10.4049/jimmunol.170.8.4397 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049032729
281 rdf:type schema:CreativeWork
282 https://www.grid.ac/institutes/grid.189509.c schema:alternateName Duke University Hospital
283 schema:name Department of Immunology, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA
284 Department of Medicine, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA
285 Department of Pathology, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA
286 Department of Surgery, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA
287 Duke Comprehensive Cancer Center, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA
288 Duke Institute for Genome Sciences & Policy, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA
289 Program in Molecular Therapeutics, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA
290 rdf:type schema:Organization
291 https://www.grid.ac/institutes/grid.26009.3d schema:alternateName Duke University
292 schema:name Department of Surgery, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA
293 Duke Comprehensive Cancer Center, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA
294 Program in Molecular Therapeutics, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA
295 rdf:type schema:Organization
296 https://www.grid.ac/institutes/grid.418152.b schema:alternateName AstraZeneca (United States)
297 schema:name MedImmune, LLC, One MedImmune Way, Gaithersburg, MD 20878, USA
298 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...